First patient enrolled in phase II study of novel cystic fibrosis treatment, BI-1265162 Oct. 17, 2019
Phase III SEQUOIA study of pegilodecakin in metastatic pancreatic cancer misses primary endpoint Oct. 16, 2019
Radiolabeled anti-CD37 monoclonal antibody shows promise in preclinical lymphoma, CLL studies Oct. 16, 2019
RSS